secwatch.observer — SEC 8-K summary
======================================

Issuer:     Climb Bio, Inc. (CLYM)
CIK:        0001768446
Form:       8-K
Filed at:   2026-06-08T20:07:47+00:00
Accession:  0001193125-26-261716
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Climb Bio stockholders elect Cumbo and Williams; reject charter amendment; approve equity plan amendment
--------------------------------------------------------------------------------

- Alexander (Bo) Cumbo elected to Board with 26,035,689 votes for; Douglas Williams with 24,505,866 votes for.
- Ratification of PricewaterhouseCoopers as FY2026 auditor: 35,206,304 for, 63,633 against, 2,552 abstain.
- Charter amendment for 'cause' removal of directors failed: 27,299,535 for, 130,187 against, 7,841,185 broker non-votes.
- 2021 Equity Incentive Plan amendment approved: 19,604,493 for, 7,810,582 against, 7,841,185 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768446/000119312526261716/0001193125-26-261716-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768446/000119312526261716/d72849d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-261716

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer